TrialThe American journal of tropical medicine and hygiene2025

Safety, Pharmacokinetics, and Activity of AT-752, a Novel Nucleotide Prodrug with Pan-Serotype Activity against Dengue Virus: A Phase 2, Randomized, Double-Blind Study.

Arantxa Horga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.